Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

Background The development of systemic treatment options leveraging the molecular
landscape of advanced thyroid cancer is a burgeoning field. This is a multidisciplinary …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …

Background In ESTIMABL1, a randomised phase 3 trial of radioactive iodine (131 I)
administration after complete surgical resection in patients with low-risk thyroid cancer, 92 …

Background: The most frequent site of recurrence of differentiated thyroid cancer (DTC) is
cervical lymph nodes (LNs), which often necessitates repeated surgical interventions and …

Background Many patients with papillary thyroid cancer (PTC) demonstrate satisfactory
outcomes. However, 8%–28% of patients with PTC show tumor recurrence, which may affect …

The aim of this study was to develop evidence-based recommendations for determining the
surgical extent in patients with locally invasive differentiated thyroid cancer (DTC). Locally …

Context Ultrasonography (US) is considered the most sensitive tool for imaging persistent or
recurrent papillary thyroid cancer (PTC) in the neck. Objective To clarify the usefulness of …

Background Completion thyroidectomy (cT) is sometimes necessary after thyroid lobectomy
(TL), and it remains controversial whether 2-stage thyroidectomy adds operative risk. This …